Prevention of heart failure in mice by an antiviral agent that inhibits type 5 cardiac adenylyl cyclase

Despite numerous discoveries from genetically engineered mice, relatively few have been translated to the bedside, mainly because it is difficult to translate from genes to drugs. This investigation examines an antiviral drug, which also has an action to selectively inhibit type 5 adenylyl cyclase (...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Iwatsubo, Kosaku, Bravo, Claudio, Uechi, Masami, Baljinnyam, Erdene, Nakamura, Takashi, Umemura, Masanari, Lai, Lo, Gao, Shumin, Yan, Lin, Zhao, Xin, Park, Misun, Qiu, Hongyu, Okumura, Satoshi, Iwatsubo, Mizuka, Vatner, Dorothy E., Vatner, Stephen F., Ishikawa, Yoshihiro
التنسيق: Artigo
اللغة:Inglês
منشور في: American Physiological Society 2012
الموضوعات:
Integrative Cardiovascular Physiology and Pathophysiology
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC3378263/
https://ncbi.nlm.nih.gov/pubmed/22505646
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajpheart.00190.2012
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة